Replies to post #3355 on Enanta Pharmaceuticals Inc (ENTA)

[alertmeipp]

Yes they are ready to become an immunology company risk reward higher but much hotter area w higher valuation even for early stage companies

So true, couple quarters from now, ENTA could be very different, especially if they have good data. Interesting time.

[go seek]

To your knowledge, has any other company researched a RSV therapeutic for PEDS?
Seems like this arena is a bit of a ‘Black Hole’. Thx.